Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Oncology
Reference46 articles.
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29.
2. Ghouri YA, Mian I, Rowe JH. Review of hepatocellular carcinoma: epidemiology, etiology, and carcinogenesis. J Carcinog. 2017;16:1.
3. Yahya SM, Fathy SA, El-Khayat ZA, El-Toukhy SE, Hamed AR, Hegazy MG, et al. Possible role of microRNA-122 in modulating multidrug resistance of hepatocellular carcinoma. Indian J Clin Biochem. 2017;33:21–30.
4. El-Toukhy SE, Fathy SA, Yahya SM, El-Khayat ZA, Hegazy MG, Heba K. Nabih. MicroRNA-122 restoration modulates alpha-fetoprotein expression in hepatocellular carcinoma treated with doxorubicin. Pharm Lett. 2016;8:29–35.
5. Castoldi M, Vujic Spasic M, Altamura S, Elmen J, Lindow M, Kiss J, et al. The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice. J Clin Invest. 2011;121:1386–96.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献